Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CATX
CATX logo

CATX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CATX News

Wall Street Analysts Adjust Ratings on Key Stocks

Feb 19 2026Benzinga

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep

Feb 17 2026Newsfilter

Perspective Therapeutics Prices $175M Public Offering to Advance Clinical Development

Feb 02 2026seekingalpha

Perspective Therapeutics Raises $175 Million in Underwritten Offering

Feb 02 2026Newsfilter

Oncolytics Biotech's Breakthroughs in Cancer Treatment

Jan 30 2026Newsfilter

Perspective Therapeutics Updates VMT-α-NET Trial Results, 39% Patient Response Rate Achieved

Jan 09 2026Globenewswire

Perspective Therapeutics CEO Thijs Spoor to Present at 2026 J.P. Morgan Healthcare Conference

Dec 18 2025Globenewswire

Truist Securities Initiates Coverage on Perspective Therapeutics with a Buy Rating and Increases Price Target to $12

Nov 24 2025Benzinga

CATX Events

02/02 16:20
Dow Jumps 515.19 Points as Trump Lowers India's Tariff to 18%
The major averages closed broadly higher as a dramatic reversal in the price of gold eased. Wall Street is kicking off February with gains as data showed manufacturing activity expanded the most since 2022, boosting optimism. Gold ultimately fell on the day, but the precious metal recovered most of an earlier plunge.Meanwhile, President Trump said on social media that, following a phone call with Indian Prime Minister Narendra Modi, he plans to lower India's reciprocal tariff rate to 18% from 25%.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Disneyreportedand provided its outlook for Q2 and FY26Oracleexpects toof gross cash proceeds in 2026Nvidia'splan to, The Wall Street Journal reported, though Bloomberg later reported that Nvidia CEO Jensen Huang said the company's new OpenAI investment will be "huge"Devon Energyand Coterra Energyagreed to, implying a combined enterprise value of $58BPresident Trump lowered India's reciprocal tariff rate tofollowing a call with India's Prime Minister Narendra Modi2. WALL STREET CALLS:William BlairPalantirto Outperform after 30% pullbackHumanato Underweight at Morgan StanleyMcDonald'sto Buy at BTIG after talks with franchiseesScotiabankFortineton less share optimism for 2026Best Buyto Neutral at JPMorgan3. AROUND THE WEB:The United Steelworkers union did not accept or reject Marathon Petroleum'slatest contract offer, Reuters saysFordheld discussions with Xiaomiover a partnership to help Chinese carmakers gain a foothold in the U.S., FT reportsAlibabahas delivered more than 100,000 units of the Zhenwu 810E, an ASIC for AI training and inference, surpassing those of its domestic rival Cambricon, SCMP reportsA consortium led by KKRis close to a deal to purchase ST Telemedia Global Data Centres, a global data center provider based in Singapore, in a deal that values the company over $10B, WSJ saysWarner Bros. Discoverywill likely allow its shareholders to vote on its Netflixagreement in March, CNBC says4. MOVERS:Brookfield Asset Managementgains after announcingPeakstone Realty Trustfor $21 per sharePerspective Therapeuticsincreases afterYextdeclines after announcing its CEO hasto acquire all shares of the companyEldoradofalls after announcing itin a C$3.8B transactionXPenglower after announcing 20,011 vehicles5. EARNINGS/GUIDANCE:Tyson Foods, with EPS and revenue beating consensusAptivand provided guidance for FY26Revvity, with CEO Prahlad Singh commenting, "We finished 2025 on a strong note"OperaTwist Bioscienceand raised its guidance for FY26INDEXES:The Dow rose 515.19, or 1.05%, to 49,407.66, the Nasdaq gained 130.29, or 0.56%, to 23,592.11, and the S&P 500 advanced 37.41, or 0.54%, to 6,976.44.
02/02 12:10
Dow Jones Index Rises 0.89% to 49,325.46 Points
The major averages were broadly higher near noon as a dramatic reversal in the of gold eased. Wall Street is kicking off February with gains as solid factory data bolstered optimism. Data showed manufacturing activity expanded the most since 2022. While gold was down 4.5% near midday, it pared most of an earlier plunge.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Disneyreportedand provided its outlook for Q2 and FY26Oracleexpects toof gross cash proceeds in 2026Nvidia'splan to invest $100B in OpenAI has stalled,, though Bloomberg later reported that Nvidia CEO Jensen Huang said the company's new OpenAI investment will be "huge"Devon Energyand Coterra Energyagreed to merger in, implying a combined enterprise value of $58BTyson Foods, with EPS and revenue beating consensus2. WALL STREET CALLS:William BlairPalantirto Outperform after 30% pullbackHumanato Underweight at Morgan StanleyMcDonald'sto Buy at BTIG after talks with franchiseesScotiabankFortineton less share optimism for 2026Best Buyto Neutral at JPMorgan3. AROUND THE WEB:Fordheld discussions with Xiaomiover a partnership to help Chinese carmakers gain a foothold in the U.S., FT reportsAlibabahas delivered more than 100,000 units of the Zhenwu 810E, an ASIC for AI training and inference, surpassing those of its domestic rival Cambricon, SCMP reportsA consortium led by KKRis close to a deal to purchase ST Telemedia Global Data Centres, a global data center provider based in Singapore, in a deal that values the company over $10B, WSJ saysTeslaCEO Elon Musk's SpaceX is seeking FCC approval to launch 1M satellites that will orbit the Earth and harness the sun to power AI data centers, Reuters saysWarner Bros. Discoverywill likely allow its shareholders to vote on its Netflixagreement in March, CNBC says4. MOVERS:Brookfield Asset Managementgains after announcing it willfor $21 per sharePerspective Therapeuticsincreases afterat $3.79Yextdeclines after announcing itshis previously announced proposal to acquire all shares of the companyEldoradofalls after announcingin a C$3.8B transactionXPenglower after announcingin January5. EARNINGS/GUIDANCEAptivand provided guidance for FY26Revvity, with CEO Prahlad Singh commenting, "We finished 2025 on a strong note"Napco Security (NSSC) reportedand raised its quarterly dividendOperaTwist Bioscienceand raised its guidance for FY26INDEXES:Near midday, the Dow was up 0.89%, or 432.99, to 49,325.46, the Nasdaq was up 0.66%, or 154.36, to 23,616.18, and the S&P 500 was up 0.56%, or 38.55, to 6,977.58.
02/02 08:51
Perspective Therapeutics Prices 39.6M Share Offering at $3.79, Raising Approximately $175M
Perspective Therapeutics announced the pricing of an underwritten offering of 39,576,088 shares of its common stock at an offering price of $3.79 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase 6,598,046 shares of its common stock at a price of $3.789 per pre-funded warrant. The aggregate gross proceeds from this offering are expected to be approximately $175M, before deducting underwriting discounts and commissions and other offering expenses payable by Perspective in connection with the offering. The purchase price per share of each pre-funded warrant represents the per share offering price for the common stock, minus the $0.001 per share exercise price of such pre-funded warrant. The offering is expected to close on or about February 3, subject to the satisfaction of customary closing conditions. All of the shares of common stock and pre-funded warrants to be sold in the offering are being sold by Perspective. The financing included participation from Commodore Capital, TCGX, Spruce Street Capital, Surveyor Capital, Affinity Asset Advisors, HBM Healthcare Investments, Ally Bridge Group and other leading healthcare specialist and long only investors. Piper Sandler, UBS Investment Bank, Oppenheimer & Co., Truist Securities and LifeSci Capital are acting as joint book-running managers for the offering.

CATX Monitor News

No data

No data

CATX Earnings Analysis

No Data

No Data

People Also Watch